Ross Operation Failure Database
- Conditions
- Ross OperationStructural Valve DegenerationPulmonary Autograft
- Interventions
- Procedure: Ross Operation
- Registration Number
- NCT03027804
- Lead Sponsor
- Centre Cardiologique du Nord
- Brief Summary
A large multicentric registry to obtain data to analyse the pulmonary autograft (PA) failure phenomenon and feed more complex biomechanical models to be integrated with clinical imaging with the final aim to predict Ross operation's outcomes and define strategies to ameliorate its results.
- Detailed Description
On the basis of the current knowledge on the outcomes of Ross Operation we aim to create a large multi centric registry in order to obtain data on the preoperative intraoperative management of these patients and on the postoperative long-term results of this procedure.
Patients data will be entered by the investigators in an electronic database Preoperative variables will include age, comorbidities, functional status, indications for surgery, morphology of the aortic valve Additional morphological data and aortic and pulmonary measurements will be taken intraoperatively Postoperative follow-up data including both clinical outcomes (mortality, reoperation for pulmonary autograft failure, major cardiac events, stroke, infection) and morphological measurements by means of CT scan or echocardiography, will be inserted.
Quality of life by means of SF12 and Minnesota living with heart failure questionnaire and EQ-5D score will be collected.
Follow-up endpoints are at discharge, 1 year 5 years 10 years 15 years and 20 years.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients undergone (or undergoing) to Ross Operation
- Patients requiring combined cardiac surgical procedure in association to Ross Operation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Ross Operation Ross Operation Patients undergone Ross Operation. Patients requiring reoperation
- Primary Outcome Measures
Name Time Method Quality of life-3 from inclusion to 20 years follow-up Quality of life as measured withEQ 5D score
Cardiac Death from inclusion to 20 years follow-up Mortality due to cardiac cause
Reoperation for Pulmonary Autograft Failure from inclusion to 20 years follow-up Need for reoperation due to failure of pulmonary autograft or valve degeneration
Quality of life-1 from inclusion to 20 years follow-up Quality of life as measured with SF-12
Rehospitalization for heart failure from inclusion to 20 years follow-up Readmission to hospital for heart failure
Survival from inclusion to 20 years follow-up Death from any cause
Stroke from inclusion to 20 years follow-up neurological stroke with impairment
Quality of life-2 from inclusion to 20 years follow-up Quality of life as measured with Minnesota living with heart failure questionnaire
- Secondary Outcome Measures
Name Time Method Postoperative complications postoperative period (1-30 days) Combined outcome including bleeding, arrhythmia, respiratory failure, renal failure
Trial Locations
- Locations (1)
Centre Cardiologique Du Nord
🇫🇷Paris, France